首页> 外文期刊>RSC Advances >Curcumin induces cell death of human papillary thyroid carcinoma BCPAP cells through endoplasmic reticulum stress
【24h】

Curcumin induces cell death of human papillary thyroid carcinoma BCPAP cells through endoplasmic reticulum stress

机译:姜黄素通过内质网胁迫引起人乳头状甲状腺癌BCPAP细胞的细胞死亡

获取原文
获取原文并翻译 | 示例
           

摘要

Curcumin, a major active component of Curcuma longa, is a natural polyphenolic antioxidant compound which has a strong potential for cancer prevention and treatment. However, the effect of curcumin on papillary thyroid carcinoma cells has not been investigated. In the present study, we report that curcumin induces cell death of papillary thyroid carcinoma (PTC) cell line BCPAP cells through endoplasmic reticulum (ER) stress. Curcumin suppressed cell viability of BCPAP cells in a dose-dependent manner. A large body of evidence demonstrates that ER stress contributes to cell death in certain contexts. ER stress was induced by curcumin treatment in BCPAP cells, as evidenced by the up-regulation of intracellular calcium level, and up-regulated expression of CCAAT/enhancer binding protein homologous protein (CHOP) at both mRNA and protein levels compared to the control group. Moreover, the activation of activating transcription factor 6 (ATF6)/X-box binding protein-1 (XBP-1) pathways could be involved in the ER stress signaling of curcumin treatment. Thus, our results provide new insights into the molecular mechanisms of curcumin-mediated cell death in PTC cells and suggest curcumin might be a potential chemotherapeutic agent which is able to fight against papillary thyroid cancer.
机译:姜黄素是一种主要活性成分的Curcuma Longa,是一种天然的多酚抗氧化剂,具有巨大的癌症预防和治疗潜力。然而,姜黄素对乳头状甲状腺癌细胞的影响尚未研究。在本研究中,我们认为姜黄素诱导乳头状甲状腺癌(PTC)细胞系BCPAP细胞的细胞死亡通过内质网(ER)应力。姜黄素以剂量依赖性方式抑制BCPAP细胞的细胞活力。大量证据表明,ER应激在某些情况下有助于细胞死亡。通过BCPAP细胞中的姜黄素治疗诱导ER应激,如针对对照组的mRNA和蛋白质水平的细胞内钙水平的上调和上调表达CCAAT / Enhancer结合蛋白同源蛋白(Chec)的上调表达。此外,活化转录因子6(ATF6)/ X型盒结合蛋白-1(XBP-1)途径的活化可参与姜黄素处理的ER应激信号传导。因此,我们的结果为PTC细胞中姜黄素介导的细胞死亡的分子机制提供了新的见解,并表明姜黄素可能是能够对抗乳头状甲状腺癌的潜在化疗剂。

著录项

  • 来源
    《RSC Advances》 |2016年第58期|共8页
  • 作者单位

    Jiangsu Inst Nucl Med Key Lab Nucl Med Minist Hlth Jiangsu Key Lab Mol Nucl Med Wuxi Jiangsu Peoples R China;

    Jiangsu Inst Nucl Med Key Lab Nucl Med Minist Hlth Jiangsu Key Lab Mol Nucl Med Wuxi Jiangsu Peoples R China;

    Jiangsu Inst Nucl Med Key Lab Nucl Med Minist Hlth Jiangsu Key Lab Mol Nucl Med Wuxi Jiangsu Peoples R China;

    Jiangsu Inst Nucl Med Key Lab Nucl Med Minist Hlth Jiangsu Key Lab Mol Nucl Med Wuxi Jiangsu Peoples R China;

    Jiangsu Inst Nucl Med Key Lab Nucl Med Minist Hlth Jiangsu Key Lab Mol Nucl Med Wuxi Jiangsu Peoples R China;

    Jiangsu Inst Nucl Med Key Lab Nucl Med Minist Hlth Jiangsu Key Lab Mol Nucl Med Wuxi Jiangsu Peoples R China;

    China Med Univ Hosp 1 Dept Endocrinol &

    Metab Shenyang 110001 Liaoning Peoples R China;

    Nanjing Univ Sch Life Sci State Key Lab Pharmaceut Biotechnol Nanjing 210008 Jiangsu Peoples R China;

    Jiangnan Univ State Key Lab Food Sci &

    Technol Sch Food Sci &

    Technol 1800 Lihu Ave Wuxi 214122 Jiangsu Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号